Finance

Beta
Lists
RZONF:OTCMKTS
Rize Oncology Ord Shs
$0.16
0.00%
(0.00) 1D
May 23, 9:57:00 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RZONF...
Mkt. cap
2.30M
Volume
0.00
52-wk high
$0.00
52-wk low
$0.00
Shares outstanding
80.74M
Mkt. cap
2.30M
Volume
0.00
52-wk high
$0.00
52-wk low
$0.00
Shares outstanding
80.74M
News stories
From sources across the web
About Rize Oncology Ord Shs
CEO-
Employees-
Founded2018
HeadquartersKelowna, British Columbia, Canada
SectorPharmaceutical industry
Websiterizeoncology.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
247.24K
243.53K
-1.55K
86.71K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
156.91K
123.52K
218.84K
144.42K
Operating expense
404.15K
367.05K
217.29K
231.13K
Total operating expenses
404.15K
367.05K
217.29K
231.13K
Operating income
-404.15K
-367.05K
-217.29K
-231.13K
Other non operating income
-
-
-
-
EBT including unusual items
-400.92K
-369.97K
-215.04K
-232.48K
EBT excluding unusual items
-400.92K
-369.97K
-215.04K
-232.48K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-400.92K
-369.97K
-215.04K
-232.48K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
3.27K
1.45K
571.00
11.00
Interest expense
-
-
-
-
Net interest expenses
3.27K
1.45K
571.00
11.00
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-152.05K
-192.62K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer